Published in

SSRN Electronic Journal, 2022

DOI: 10.2139/ssrn.4158289

Elsevier, European Journal of Cancer, (175), p. 204-213, 2022

DOI: 10.1016/j.ejca.2022.08.024

Links

Tools

Export citation

Search in Google Scholar

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

Journal article published in 2022 by Claudia Angela Maria Fulgenzi, Fulgenzi Cam, Jaekyung Cheon, Antonio D'Alessio, Naoshi Nishida, Celina Ang, Thomas U. Marron, Marron Tu, Linda Wu, Anwaar Saeed ORCID, Brooke Wietharn ORCID, Antonella Cammarota ORCID, Tiziana Pressiani, Nicola Personeni ORCID, Matthias Pinter and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO